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Summary
Intrinsic resistance to multiple drugs in many gram-
negative bacterial pathogens is conferred by resis-
tance nodulation cell division efflux pumps, which
are composed of three essential components as typi-
fied by the extensively characterized Escherichia coli
AcrA-AcrB-TolC system. The inner membrane drug:
proton antiporter AcrB and the outer membrane chan-
nel TolC export chemically diverse compounds out of
the bacterial cell, and require the activity of the third
component, the periplasmic protein AcrA. The crystal
structures of AcrB and TolC have previously been de-
termined, and we complete the molecular picture of
the efflux system by presenting the structure of a sta-
ble fragment of AcrA. The AcrA fragment resembles
the elongated sickle shape of its homolog Pseudomo-
nas aeruginosa MexA, being composed of three do-
mains: b-barrel, lipoyl, and a-helical hairpin. Notably,
unsuspected conformational flexibility in the a-helical
hairpin domain of AcrA is observed, which has poten-
tial mechanistic significance in coupling between
AcrA conformations and TolC channel opening.
Introduction
The rising incidence of multidrug-resistant bacterial
pathogens poses a serious threat to human health. In-
trinsic multidrug resistance is conferred in a number of
gram-negative bacterial pathogens, including Pseudo-
monas aeruginosa and Haemophilus influenzae, by
transporters belonging to the resistance nodulation cell
division (RND) family of proteins (Putman et al., 2000;
Walsh, 2000). RND-type transporters utilize the proton
electrochemical gradient to energize efflux of antibiotics
and other compounds out of the bacterial cell. The major
mechanistic feature of these transporters is the ability to
transfer multiple substrates across both the inner and
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nia 92037.the outer membranes of gram-negative bacteria directly
into external media without periplasmic intermediates
(Thanassi et al., 1995). To achieve drug efflux across
two membranes, RND-type transporters assemble into
multiprotein efflux systems. Two of the most extensively
characterized RND multidrug efflux systems are Escher-
ichia coli AcrA-AcrB-TolC and P. aeruginosa MexA-
MexB-OprM (Hirakata et al., 2002; Ma et al., 1995).
RND systems consist of large complexes of three es-
sential components. The first is an RND inner membrane
protein, which is energized by the proton-motive force.
The RND inner membrane protein assembles into a tri-
mer, as shown by the X-ray crystal structure of the pro-
ton antiporter AcrB (Murakami et al., 2002; Yu et al.,
2003). Each protomer of the trimer has 12 transmem-
brane a-helical segments and two large w300 residue
periplasmic domains that extendw70 A˚ above the plane
of the inner membrane. Chemically diverse substrates,
such as rhodamine 6G, ethidium, dequalinium, and ci-
profloxacin, have been seen to bind through hydropho-
bic interactions to a central cavity in the periplasmic do-
main (Murakami et al., 2002; Yu et al., 2003). How these
compounds are pumped outward from their binding
sites is not yet known.
The second essential component of the RND system is
an outer membrane protein, also known as outer mem-
brane factor (OMF), that like the RND inner membrane
protein is trimeric. The structures of the OMFs E. coli
TolC, P. aeruginosa OprM, and Vibrio cholerae VceC
have been determined (Akama et al., 2004a; Federici
et al., 2005; Koronakis et al., 2000), revealing similarly
shaped cylindrical channels. The trimeric channel is em-
bedded in the outer membrane as a 12 stranded b-barrel
that continuesw100 A˚ into the periplasmic space as an
a-helical barrel. TolC, OprM, and VceC have been visual-
ized in their closed states, and hypothesized to open
through an iris-like mechanism (Andersen et al., 2002;
Koronakis et al., 2000). TolC has been shown to interact
physically with AcrB by chemical crosslinking and inter-
molecular disulfide bond formation experiments (Ta-
mura et al., 2005; Tikhonova and Zgurskaya, 2004; Touze
et al., 2004). This interaction suggests that substrates are
transported directly from the RND inner membrane pro-
tein through the open OMF channel and out into the ex-
tracellular space.
The third essential component is a periplasmic protein
that belongs to the membrane fusion protein (MFP) fam-
ily (Dinh et al., 1994; Saier et al., 1994), named for se-
quence similarity in these proteins to the membrane fu-
sion protein (F protein) of paramyxovirus 5 (Dinh et al.,
1994; Saier et al., 1994). Interestingly, MFPs are not
only essential components of RND systems but also of
other energy-dependent transport systems, such as the
ATP binding cassette (ABC) system and the major facili-
tator system (MFS) (Putman et al., 2000). MFPs are at-
tached to the inner membrane via lipid acylation of a cys-
teine residue or through an N-terminal transmembrane
segment. However, membrane attachment is not essen-
tial for drug efflux activity, as seen by the functionality of
soluble, periplasmic mutants of theE. coliMFP AcrA and
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578Figure 1. Domain Mapping of AcrA(26–397)
by Thermolytic Digestion
AcrA(26–397) was digested with thermolysin
for 0, 1, 2, and 4 hr (lanes A, B, C, D, respec-
tively) at a 50:1 (mass) substrate:protease
ratio and analyzed by 12% SDS-PAGE.
Molecular weights and schematics of proteo-
lytic products are shown to the right of the
corresponding fragments. Fragments were
identified by N-terminal sequencing and
mass spectrometry.the P. aeruginosa MFP MexA (Yoneyama et al., 2000;
Zgurskaya and Nikaido, 1999a). AcrA has been shown
to interact physically with both AcrB and TolC (Husain
et al., 2004; Tikhonova and Zgurskaya, 2004; Touze
et al., 2004; Zgurskaya and Nikaido, 2000). Recent exper-
imental evidence indicates that interaction of AcrA with
these components is likely to play an active role in the
efflux process (Aires and Nikaido, 2005; Zgurskaya and
Nikaido, 1999b).
In this study, we have determined the 2.7 A˚ resolution
X-ray crystal structure of the stable core of AcrA, thereby
helping to complete the atomic resolution model of the
AcrA-AcrB-TolC drug extrusion system and providing
a point of comparison to recently determined structures
of the P. aeruginosa MFP MexA (Akama et al., 2004b;
Higgins et al., 2004). The structure of AcrA is found to
provide unsuspected evidence for conformational flexi-
bility in MFPs. Intriguingly, this flexibility coincides with
conformational changes predicted to occur during open-
ing of OMF channels by an iris-like mechanism.
Results
Domain Mapping of AcrA
AcrA was subjected to limited proteolytic digestion to
map its domain architecture. For this purpose, a soluble
form of mature AcrA (residues 26–397, 40 kDa), which
lacks the cleaved signal sequence (residues 1–24) and
the lipid acylation site at residue Cys-25, was expressed
cytoplasmically in E. coli and purified using an intro-
duced C-terminal histidine tag (Figure 1). This cytoplas-
mically expressed, soluble form of AcrA has been shown
to be functional in restoring in vivo drug efflux activity to
a DacrA strain of E. coli (Zgurskaya and Nikaido, 1999a).
After 1 hr of digestion with the relatively nonspecific pro-
tease thermolysin at a 50:1 substrate:protease (mass)
ratio, AcrA is found to be trimmed slightly at its N- and
C-terminal ends. The resulting 38 kDa products begin
heterogeneously at either residue 26 or 30 and end ho-
mogeneously at residue 386, as determined by N-termi-
nal sequencing and mass spectrometry. These products
are further digested over the next two to four hours to
yield the stable, protease-resistant core of AcrA (Fig-
ure 1). The 28 kDa stable core begins at residue 45 and
ends heterogeneously at residue 305 or 312. This ther-
molytic fragment is very similar to a recently reported
tryptic fragment of AcrA that encompasses residues
45–315 (Touze et al., 2004).These results demonstrate that the w90 C-terminal
residues of AcrA are likely to be flexible and hence pro-
teolytically sensitive. The C-terminal residues (313–397)
removed from AcrA by proteolysis are digested into
small peptides and do not yield a resistant fragment.
This proteolytically sensitive C-terminal region of AcrA
is required for association with the inner membrane
RND protein AcrB, as shown by chimera studies using
AcrA residues 290–357 and direct binding studies using
an AcrA fragment composed of residues 172–397 (Elkins
and Nikaido, 2003; Touze et al., 2004). The C-terminal re-
gion also appears to be required for interaction with
TolC (Touze et al., 2004). The flexibility of both N- and
C-terminal regions of AcrA is also consistent with X-ray
crystal structures of the homolog MexA, the periplasmic
component of the P. aeruginosa MexA-MexB-OprM
multidrug efflux system (Akama et al., 2004b; Higgins
et al., 2004). Although intact mature MexA, with a molec-
ular weight of 38 kDa, had been crystallized, electron
density was observed only for a region of the protein
equivalent to the 28 kDa stable core of AcrA.
Structure Determination of the Stable Core of AcrA
To gain functional insight, we set out to crystallize the 28
kDa stable core of AcrA (residues 45–312). Although
AcrA(45–312) was found to readily crystallize (e.g., under
one fifth of Hampton crystal screen I and II conditions),
almost all crystals were found to diffract anisotropically
to a maximum resolution of only 5–10 A˚. Only one condi-
tion was identified to yield crystals that diffracted X-rays
to a reasonable resolution limit (w3.5 A˚). These crystals
appeared to belong to space group P42212, but were
discovered, after several unsuccessful attempts at ob-
taining phase information, to have arisen through
a rare case of perfect pseudomerohedral twinning of
P212121 crystals, in which the a and b axes are fortu-
itously identical in length (169 A˚). Analysis of intensity
distributions in local areas of reciprocal space proved
instrumental in detecting pseudomerohedral twinning
in these crystals (Padilla and Yeates, 2003).
Due to great difficulties in determining structures from
perfectly twinned crystals, an alternate crystal form was
sought. Untwinned crystals that diffracted X-rays iso-
tropically to 2.7 A˚ resolution were obtained from a qua-
druple methionine substitution mutant (F223M, L224M,
L287M, and L288M) which had been constructed for
the purpose of multiwavelength anomalous dispersion
(MAD) phase determination. Wild-type AcrA(45–312)
also crystallized under essentially the same conditions
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(A) Ribbon representation of AcrA(45–312)-
4M, showing two apparent dimers per asym-
metric unit in the crystal.
(B) Ribbon representation of a monomer of
AcrA(45–312)-4M (molecule C), with the a-he-
lical hairpin domain in red, lipoyl domain in
green, and b-barrel domain in cyan. Molecu-
lar graphics were made with PyMOL (DeLano,
2002).as the quadruple methionine substitution mutant, called
AcrA(45–312)-4M, but diffracted X-rays anisotropically
to a maximum resolution of only 3.3 A˚ resolution. Crys-
tals of AcrA(45–312)-4M contain four molecules per
asymmetric unit and a solvent content of 60%. The struc-
ture was determined by MAD techniques using seleno-
methionine-labeled protein. Continuous electron density
for the main chain from residue 53 to 299 is observed in
one of the monomers (Figure 2A, labeled C), whereas
small breaks (at residues 230–241) are observed in the
other three monomers (Figure 2A, labeled A, B, and D).
The model has been refined to 2.71 A˚ resolution with an
Rwork of 23.7% and an Rfree of 27.5% (Table 1).
Overview of the Structure
The four molecules of AcrA(45–312)-4M in the asymmet-
ric unit of the crystal pack as an apparent dimer ofdimers. The molecules labeled A and B are related to
one another by approximate dyad symmetry, as are
the molecules labeled C and D; each set of dimers is in
turn related to one another by yet another approximate
2-fold axis (Figure 2A). Close structural relationship is
seen (and detailed below) between AcrA(45–312)-4M
and MexA, which is not surprising given their 62% and
73% sequence identities and similarities, respectively.
Despite the close sequence and structural similarity,
the two proteins do not functionally complement each
other (Tikhonova et al., 2002). Both AcrA(45–312)-4M
and MexA are elongated, sickle-shaped molecules com-
prised of three domains: a b-barrel domain at one end,
a lipoyl domain centrally located, and a coiled-coil a-he-
lical hairpin at the other end of the molecule (Figure 2B).
The existence in MFPs of the lipoyl and a-helical hairpin
domains had been predicted from primary sequence
Structure
580Table 1. X-Ray Data Collection and Refinement, AcrA(45–312)-4M
Data Collection
Beamline APS-BM19 ALS-8.2.2
Data set l1 l2 l3 l1
Wavelength (A˚) 0.97938 0.97955 0.96415 1.0000
Resolution (A˚)a 50–3.00 (3.11–3.00) 50–3.39 (3.59–3.39) 50–3.50 (3.63–3.50) 50–2.70 (2.77–2.70)
Completeness (%) 99.3 (99.3) 99.8 (99.9) 99.8 (99.9) 97.3 (91.1)
Redundancy 4.2 (3.4) 4.4 (4.5) 4.2 (3.8) 5.0 (3.9)
I/s 13.5 (2.3) 16.6 (4.6) 12.0 (4.0) 14.6 (2.3)
Rmerge
b 13.9 (76.1) 9.8 (38.9) 18.5 (53.4) 9.0 (42.9)
Phasing
Se l1 Se l2 Se l3
Anomalous and dispersive differences (%)c
Se l1 4.2
Se l2 1.8 2.4
Se l3 2.0 3.8 3.1
Anomalous phasing powerd 1.5 0.8 0.7
Number of sites 16
Figure of merit (40–3.0 A˚) 0.59
Refinement
Resolution 50.0–2.71 (2.77–2.71)
Rcryst (%)
e 23.7 (40.8) Rms deviation
Rfree (%)
e 27.5 (47.4) Bonded B factor (A˚2) 3.30
Number of reflections From ideal geometry
Working set 35,426 Lengths (A˚) 0.010
Test set 1,873 Angles (º) 1.608
Number of atoms Average B factors (A˚2)
Protein 6936 Protein 89.2
Solvent 36 Solvent 64.0
a Highest resolution shell is in parentheses.
b Rmerge = 1003
P
h
P
i
jIh; i 2 Ihj
P
h
P
i
Ih; i
, where Ih is the mean intensity of symmetry-related reflections, Ih,j.
c Anomalous and dispersive differences = 100 3 rms DF/rms F, where DF for anomalous differences is (F+h – F2h)/2 (diagonal element) and for
dispersive differences is Fli – Flj (off-diagonal).
d FH00/E, with FH00 being the anomalous component of the heavy atom structure factor and E the rms lack-of-closure error.
e R factor = 1003
P
hkl
jFobs2Fcalcj
P
hkl
Fobs
, where Rfree is calculated for a randomly chosen 5% of reflections (F > 0) omitted from refinement, and Rcryst is
calculated for the remaining 95% of reflections (F > 0) included in refinement.considerations alone (Johnson and Church, 1999). The
a-helical hairpin in AcrA is seven residues longer than
in MexA, resulting in a total length of 105 A˚ for AcrA as
compared to the 89 A˚ length of MexA.
b-Barrel Domain
The b-barrel domain consists of six antiparallel b strands
and a short a helix (Figure 2B). The N and C termini of the
AcrA fragment form two of the apposing strands (b1, res-
idues 54–61 and b14, residues 292–297, respectively).
This domain is predicted to be proximal in vivo to the in-
ner membrane due to lipid acylation of Cys-25. The 28
flexible residues connecting Cys-25 to the b-barrel do-
main are more than sufficient to reach the periplasmic
top of AcrB, which extendsw70 A˚ above the inner mem-
brane surface (Murakami et al., 2002; Yu et al., 2003). The
short a helix (a3, residues 222–230) is located between
b strands 10 and 11, and closes off the end of the b-barrel
near the C terminus of the AcrA fragment. This helix in in-
tact AcrA would, therefore, lie close to the flexible, pro-
teolytically sensitive C-terminal 100 residues that are re-
quired for interaction with AcrB and TolC (Elkins and
Nikaido, 2003; Touze et al., 2004).The b-barrel domain is the site of all four methionine
substitutions introduced for crystallization and phasing
purposes. Two of the methionine substitutions, at posi-
tions 223 and 224, are located on the a3 helix, and the
other two, at positions 287 and 288, on a loop connecting
b strands 13 and 14 (Figure 3). Among these four substi-
tutions, the only methionine that makes intermolecular
contacts (within 4 A˚) is Met-288 (molecules A and C),
which abuts residues Val-265 and Val-267. The adjacent
methionine substitution Met-287 makes intramolecular
contacts, and is positioned against a hydrophobic
pocket formed by residues Phe-254, Leu-246, and Met-
291 near the center of the molecule’s b-barrel domain.
Overall, the b-barrel domains of all four AcrA molecules
are found to be structurally similar (rmsd 1.02 A˚, 63 Ca
atoms).
Lipoyl and Coiled-Coil Domains
The central portion of AcrA consists of a lipoyl domain,
best thought of as two lipoyl half-motifs interrupted by
an a-helical hairpin formed by helices a1 and a2 (Figure
2B). The N- and C-terminal lipoyl half-motifs are homol-
ogous to each other (Johnson and Church, 1999) and
consist of four b strands (b2–b5 and b6–b9, respectively)
Structure of AcrA
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(A) Sequence alignment of the a-helical hairpins of AcrA and MexA. The corresponding heptad position is shown above the sequence with res-
idues in the c and f positions highlighted in gray (including Ala-99, which is situated at a c position but is a b position residue according to se-
quence) and hydrogen bonding residues in cyan.
(B) Parallel interactions of AcrA(45–312)-4M. Molecules A and B make similar dimeric contacts as molecules C and D, with the latter pair being
shown here in Ca trace. Side chains are shown for residues in the c and f heptad positions as well as for residues that were substituted with
methionine. The boxed region is enlarged at right, with hydrogen bonds colored in cyan. Below is a cross-section of the a-helical hairpin showing
the intra- and intermolecular packing between helices. The positions of the heptad repeat are labeled a–g with side chains for the a and d heptad
positions shown in yellow, and the e and f heptad positions shown in gray.
(C) Parallel interactions of MexA. Molecules A and B of the 13 total molecules in the asymmetric unit of MexA are shown, with representation as
in (B).
(D) Antiparallel interactions of AcrA(45–312)-4M, with molecules related by crystallographic symmetry. Representation as in (B).
(E) Antiparallel interactions of MexA, with molecules G and H shown and representation as in (B).
Structure
582Table 2. Antimicrobial Susceptibility of E. coli Cells Expressing Wild-Type and Mutant AcrA
Minimum Inhibitory Concentration (mg/ml)
pUC18 AcrA AcrA F223M/L224Ma AcrA L287M/L288Mb AcrA-4Mc AcrA(1–312)
Erythromycin 2 64 128 128 2 2
Novobiocin 4 128 256 256 2 1
Ethidium bromide 6.25 100 100 100 6.25 6.25
SDS 62.5 >2000 >2000 >2000 62.5 40
Puromycin 2 256 256 256 2 ND
ND, not determined.
a AcrA(1–397) F223M/L224M.
b AcrA(1–397) L287M/L288M.
c AcrA(1–397) F223M/L224M/L287M/L288M.that intertwine with one another to form a b sandwich.
Lipoyl domains generally serve as carriers of lipoyl or
biotinyl cofactors, which are attached to a conserved
lysine on a loop connecting the two half-motifs. In
AcrA and other MFPs, a coiled-coil a-helical hairpin
intervenes between the lipoyl half-motifs instead of a
lysine-containing loop.
The coiled-coil a-helical hairpin is 58 A˚ long and has
five heptad repeats per helix. This is longer than the 47
A˚ long a-helical hairpin of MexA, which has four rather
than five heptad repeats. The additional heptad in
AcrA is located at residues 120–126 and 142–148, and
entirely accounts for the difference in length between
AcrA and MexA (Figure 3A). In general, MFPs are found
to have coiled-coil lengths varying between four and six
heptad repeats per helix. As seen with MexA, packing
between the two helices (a1, residues 99–130; a2, resi-
dues 140–172) resembles canonical knobs-into-holes
packing of hydrophobic side chains in the a and d posi-
tions of the heptad repeat (Akama et al., 2004b; Higgins
et al., 2004; Johnson and Church, 1999). Also as seen in
MexA, the left-handed superhelical coiling in the a1 helix
is more pronounced than in the a2 helix, so that a2 ap-
pears to be relatively straighter than a1.
Functional Properties of Methionine
Substitution Mutants
While the methionine mutations introduced for phasing
have no apparent effect on protein stability in vitro,
they have surprising effects on AcrA-AcrB-TolC efflux
activity in vivo. To understand in vivo activity, we first
asked whether AcrA truncated at residue 312 confers
drug resistance. AcrA(1–312) was placed under control
of its native promoter in an operon that also contains
acrB. This operon was expressed in a strain of E. coli
that lacks AcrAB and its close homolog AcrEF (DacrAB-
DacrEF). AcrA(1–312) contains its endogenous signal
sequence, which directs it to the periplasm and pro-
motes its attachment to the inner membrane via lipid ac-
ylation of Cys-25. The strain expressing AcrA(1–312)
was found to be highly susceptible to a number of
AcrA-AcrB-TolC substrates, including erythromycin, no-
vobiocin, ethidium bromide, sodium dodecyl sulfate,
and puromycin (Table 2). Interestingly, the truncation
mutant was seen to have a drastically lower steady-
state level of protein expression than wild-type AcrA
(Figure 4).
Because truncation at residue 312 abrogates steady-
state protein expression and function, the methioninesubstitutions were introduced as double or quadruple
substitutions into intact AcrA for functional assays.
Both AcrA F223M/L224M and AcrA L287M/L288M,
when directed to the periplasm for attachment to the in-
ner membrane through Cys-25, were found to confer re-
sistance to various compounds at levels nearly or fully
equivalent to wild-type AcrA (Table 2). Surprisingly, the
quadruple substitution mutant, AcrA F223M/L224M/
L287M/L288M, did not confer resistance (Table 2).
Steady-state protein expression levels of the two double
methionine substitutions are at levels approximately
equivalent to that of wild-type AcrA. In contrast, the
steady-state expression level of the quadruple substitu-
tion mutant was undetectable, as was also the case for
the truncation mutant (Figure 4).
It is not readily apparent why such large differences
exist between the double and the quadruple substitution
mutants. Association among RND components has
been observed to promote stability (Tikhonova et al.,
2002), and so it is possible that the low steady-state
levels of some of the AcrA mutants above reflect com-
promised affinity for AcrB, TolC, or both. However, other
explanations are possible and remain to be tested.
Packing of AcrA Monomers
Unlike trimeric AcrB and TolC, the association state of
AcrA is uncertain. While soluble forms of AcrA and
MexA have been found to be monomeric in vitro, cross-
linking of AcrA in vivo suggests a trimeric form (Akama
et al., 2004b; Higgins et al., 2004; Zgurskaya and Ni-
kaido, 1999a, 2000). In crystals, both AcrA and MexA
are observed to form oligomers involving similar sets
of contacts. For AcrA, two molecules in parallel orienta-
tion associate as a dimer through extensive contacts
involving the a-helical hairpins as well as adjoining lipoyl
and b-barrel domains (Figure 3B). Approximately
1650 A˚2 of surface area per molecule is buried at this
interface. The same interactions are seen in MexA be-
tween adjacent molecules (Figure 3C), but in MexA,
they are extended beyond dimers to form unusual six-
and seven-membered superhelical rings that associate
head to head (Akama et al., 2004b; Higgins et al., 2004).
The parallel intermolecular association observed in
both AcrA and MexA crystals involves antiparallel inter-
action of the a1 helix of one monomer with the a2 helix of
a second monomer (Figures 3B and 3C). The association
involves knobs-into-holes packing of residues at c and f
positions in AcrA, as assessed using the Socket algo-
rithm (Figure 3B) (Walshaw and Woolfson, 2001). The
Structure of AcrA
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knobs-into-holes packing (Figure 3C). As noted previ-
ously (Higgins et al., 2004), residues at c and f positions
are generally conserved between AcrA and MexA (Fig-
ure 3A) as well as in other MFPs.
In addition to parallel associations, extensive antipar-
allel associations are observed. This occurs in the crys-
tallographic packing of adjacent AcrA molecules and
noncrystallographic packing of six- and seven-mem-
bered rings of MexA (Figures 3D and 3E). In the case
of antiparallel association, adjacent equivalent helices,
a1 for MexA and a2 for AcrA, pack in antiparallel fashion
and contribute residues predominantly at the c and f po-
sitions to the interface. Therefore, the observation that
MFPs are monomeric in solution but oligomeric in the
high-concentration environment of crystals may be rec-
onciled by the propensity of their a-helical hairpins to in-
teract homotypically.
Conformational Flexibility of the a-Helical
Hairpin Domain
Four conformations of AcrA(45–312)-4M have been cap-
tured in the crystal and provide evidence for flexibility of
the hinge between the a-helical hairpin and lipoyl do-
main (Figure 5). The greatest variation is between AcrA
molecules B and C (Figure 5A). Using the lipoyl domain
as a reference, the a-helical hairpins of molecules B
and C are found to differ by w15º overall and by 21 A˚
at the loop located at the tip of the hairpin. The lipoyl do-
main, which is connected to the base of the hairpin, su-
perposes with high structural similarity in all four AcrA
molecules (rmsd 0.12 A˚, 66 Ca atoms). Superposition
of the a-helical domains alone also shows the hairpins
to be similar (rmsd 0.46 A˚, 51 Ca atoms). The conforma-
tion flexibility evident in AcrA contrasts with MexA,
which has essentially the same conformation in all 13
views captured in its crystal (maximum rmsd 1.17 A˚,
230 Ca atoms) (Figure 5B). Notably, molecule D of
Figure 4. Steady-State Expression of AcrA and Mutants
Western blotting analysis with anti-AcrA antibodies of total cell pro-
tein (1 mg per lane) separated on an SDS-polyacrylamide (12%) gel.
AcrA was expressed along with AcrB under control of the native
acrAB promoter from various derivatives of pAHisB plasmid in
E. coli AG100AX (DacrAB::kan DacrEF::spe). Steady-state expres-
sion of intact AcrA(1–397) (WT), AcrA L287M/L288M, AcrA F223M/
L224M, AcrA F223M/L224M/L287M/L288M, and AcrA(1–312) is
shown.AcrA has nearly the same a-helical hairpin orientation
as the one seen in MexA (rmsd 0.85 A˚, 183 Ca atoms)
(Figure 5C). Thus, the AcrA crystal captures a range of
a-helical hairpin orientations including the one observed
for MexA.
The difference in orientation of the a-helical hairpin of
AcrA stems from an effective hinge located at the base
of the hairpin. The hinge is composed of residues
99–106 in a1 and 169–173 in a2 (Figure 3A). This part
of the coiled-coil in AcrA is underwound in molecules
A and C, having aw200 A˚ pitch that is greater than the
150 A˚ pitch of a canonical a-helical coiled-coil (Seo
and Cohen, 1993). This part also has imperfect knobs-
into-holes packing. A canonical coiled-coil pitch (w150
A˚) and knobs-into-holes packing is evident in the rest
of the a-helical coiled-coil. In contrast to molecules A
and C, the hinge regions of molecules B and D are ob-
served to have a nearly canonical coiled-coil pitch.
Thus, the four conformations of AcrA taken together in-
dicate that the base of the a-helical hairpin domain ac-
commodates variation in helical winding and thereby
permits hinge-like flexion of the rigid body of this do-
main.
Discussion
We have carried out biochemical and structural studies
on the membrane fusion protein AcrA. Thermolytic do-
main mapping of AcrA revealed a stable central core to
the protein similar to the one observed crystallographi-
cally in MexA (Akama et al., 2004b; Higgins et al., 2004)
and recently reported from tryptic digestion of AcrA
(Touze et al., 2004). We also found that AcrA strongly re-
sembles MexA in three-dimensional structure, which is
not surprising given their high sequence identity. How-
ever, an unsuspected and potentially significant aspect
of AcrA was revealed in the four conformations of the
molecule seen in the crystal. In particular, these confor-
mations provide evidence for hinge-like conformational
flexibility at the base of the a-helical hairpin domain of
AcrA. The magnitude of this conformational flexibility
is remarkably congruent with conformational changes
implicated in opening of the OMF channel (Figure 6) (An-
dersen et al., 2002; Koronakis et al., 2000).
In the OMFs TolC, OprM, and VceA, the periplasmic
entrance to the channel is blocked by coiled-coil helices,
termed inner helices (H7 and H8) (Akama et al., 2004b;
Federici et al., 2005; Higgins et al., 2004). The inner heli-
ces along with a second pair of coiled-coil helices,
termed outer helices (H3 and H4), constitute the peri-
plasmic a-helical barrel of OMFs. Opening of the chan-
nel requires movement of the inner helices from the cen-
ter to the periphery of the channel. This movement is
suggested to involve an iris-like untwisting of the inner
helices, which have a canonical coiled-coil conforma-
tion, to resemble the noncanonical coiled-coil confor-
mation of the outer helices (H3 and H4) (Koronakis
et al., 2000). This iris-like opening model is supported
by the fact that the inner and outer pairs of helices are
similar in sequence, suggesting that both canonical
and noncanonical coiled-coil conformations are avail-
able to them. The model is further supported by muta-
tional data (Andersen et al., 2002).
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584Figure 5. Conformational Flexibility of a-Helical Hairpin
(A) Comparison of four conformations of AcrA(45–312)-4M observed in the crystal, with molecules A, B, C, and D superposed on the lipoyl domain
and displayed as Ca traces. The greatest difference,w15º, is between molecules B and C.
(B) Comparison of the 13 conformations of MexA observed in its crystal, with molecules superposed on the lipoyl domain and displayed as Ca
traces.
(C) Superposition of molecule B of AcrA(45–312)-4M (orange) and molecule M of MexA (purple), with molecules superposed on all domains and
displayed as Ca traces.AcrA, which has been shown to associate with both
TolC and AcrB (Husain et al., 2004; Tikhonova and Zgur-
skaya, 2004; Touze et al., 2004; Zgurskaya and Nikaido,
2000), may therefore not only promote the formation and
maintenance of the tripartite AcrA-AcrB-TolC complex,
but also may function in the opening of the TolC channel.An appealing model is for the coiled-coil hairpin of AcrA
to engage the coiled-coils of TolC. Interestingly, model-
ing of just this interaction by docking and energy minimi-
zation required a hinge-like rearrangement of the a-heli-
cal hairpin domain of AcrA (Fernandez-Recio et al.,
2004). Further studies are required to determine whether
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play an active role in the opening of the TolC channel
in response to drug efflux, or a passive role in maintain-
ing contact between AcrA and the open channel state of
the TolC channel. Additional evidence for conforma-
tional flexibility in AcrA has been obtained from electron
paramagnetic resonance studies (Ip et al., 2003). De-
spite the similarities between the conformational flexi-
bility of AcrA seen in the crystal structure and the pre-
dicted iris-like opening of TolC, it is currently unclear
how AcrA and TolC specifically associate.
While conformational flexibility is evident in AcrA, the
13 copies of MexA in the crystal are seen to have essen-
tially the same conformation (Figure 5B) (Akama et al.,
2004b; Higgins et al., 2004). However, it must be noted
that MexA molecules are closely packed in the crystal
into six- and seven-membered rings, and this may con-
strain the flexibility of the hairpin to one orientation. The
unusual oligomeric state seen in the MexA crystals is not
believed to be biologically relevant because the stack-
ing of the six- and seven-membered rings is incompati-
ble with the anchoring of MexA to the inner membrane.
Figure 6. Comparison of the TolC and AcrA(45–312)-4M Coiled-
Coils
The magnitude of conformational change predicted for the opening
of the TolC channel coincides with the flexibility observed in the
AcrA a-helical hairpin domain. The inner (yellow) and outer helices
(blue) of TolC are shown superposed based on the internal structural
repeat (residues 16–98 and 222–316). Below these are molecules B
(red) and C (green) of AcrA(45–312)-4M, as superposed on the lipoyl
domain. Direct engagement of AcrA and TolC is not modeled.Furthermore, the diameter of each ring is likely to be in-
sufficient to accommodate the inner membrane RND
protein MexB.
Recent results suggest a more complicated mode of
interaction between MFPs and OMFs than simple en-
gagement of opposing coiled-coils. Most significantly,
the tryptic fragment of AcrA, composed of residues
45–315, has been found to be insufficient to bind TolC
(Touze et al., 2004). Similarly, the thermolytic fragment
of AcrA studied here, residues 45–312, was not detected
by chemical crosslinking to associate with TolC (data
not shown). These results suggest a requirement for ei-
ther or both the N- and C-terminal portions lacking in
truncated AcrA for interaction with TolC. Because the
proteolytically sensitive w20 residue N-terminal region
of AcrA tethers the molecule to the inner membrane
and is predicted to be distal from the periplasmic end
of the molecule, it seems unlikely that it confers TolC as-
sociation. The region more likely required for associa-
tion with TolC is the proteolytically sensitive C-terminal
w90 residues of AcrA, which are also implicated in con-
ferring association with the inner membrane protein
AcrB (Elkins and Nikaido, 2003; Touze et al., 2004). In ad-
dition to the C-terminal region, the b-barrel domain of
AcrA has also been implicated in conferring TolC asso-
ciation. This implication comes from mutations in AcrA
that suppress the drug hypersensitivity phenotype of
a TolC mutant being found in the b-barrel domain
(Gerken and Misra, 2004).
Whether the b-barrel and C-terminal regions of AcrA
directly affect TolC association is not clear. One possi-
bility is that these regions mediate AcrA oligomerization
and therefore indirectly influence TolC association. The
stoichiometry of AcrA remains uncertain, with a trimeric
form found in vivo but a monomeric form in vitro (Zgur-
skaya and Nikaido, 1999a, 2000). Similarly, MexA is
found to be monomeric in vitro (Akama et al., 2004b; Hig-
gins et al., 2004). The monomeric forms of both AcrA and
MexA lack membrane anchors and are observed to form
oligomers at high concentrations used for crystalliza-
tion. In both crystal structures of AcrA and MexA, con-
served residues at the c and f positions of the a-helical
hairpin heptad repeat along with residues in the b-barrel
domain are seen to mediate similar homotypic interac-
tions. It is possible that oligomeric contacts, which ap-
pear to be weak in the absence of a membrane anchor,
may be strengthened in vivo by confinement to the two-
dimensional surface of the inner membrane, association
with other RND components, or both. Clearly more
structural and biochemical studies are need to clear
up such ambiguities and determine whether hinge-like
flexibility in the helical hairpin domain of AcrA has mech-
anistic significance. The structure of AcrA(45–312) pre-
sented here completes the picture of the AcrA-AcrB-
TolC efflux system, and serves as a guide for future
studies in the elucidation of the function of MFPs and as-
sembly of multidrug efflux pumps.
Experimental Procedures
Cloning, Expression, and Purification
Coding sequences for AcrA(26–397) and (45–312) were amplified
using PCR from E. coli JM101 chromosomal DNA and ligated into
the NcoI and XhoI restriction sites of pET28b (Novagen). These
Structure
586constructs contain a C-terminal His tag (LEHHHHHH) for purposes
of protein purification. The methionine substitution mutations
F223M/L224M and L287M/L288M were introduced by site-directed
mutagenesis using strand overlap extension PCR (Higuchi et al.,
1988).
Expression of AcrA(26–397) was induced in E. coli BL21 (DE3) us-
ing 1 mM isopropyl-b-D-thiogalactopyranoside (25ºC). Bacteria
were harvested by centrifugation and lysed by sonication (in 50
mM phosphate buffer [pH 8.0], 150 mM NaCl, 10 mM imidazole),
and AcrA(26–397) was purified by Ni2+ chelation chromatography
(Poros MC). Pooled fractions were dialyzed (50 mM Tris [pH 8.0],
150 mM NaCl), concentrated using Amicon ultrafiltration (MW cutoff
30 kDa; Millipore), and applied to a size exclusion column (Superdex
200). Purified AcrA(26–397)-His was concentrated to w30 mg/ml
(calculated e280 of 17,210 M
21 cm21), dialyzed in 10 mM Tris (pH
8.0), and flash frozen at280ºC. AcrA(45–397) was expressed and pu-
rified similarly.
Selenomethionine was incorporated into a quadruple methionine
mutant (F223M, L224M, L287M, and L288M) as described previously
(Budisa et al., 1995) and purified as above, except for the addition of
1 mM dithiothreitol to samples following Ni2+ chelation chromatog-
raphy. Purified protein was concentrated (calculated e280 of 11,520
M21 cm21), dialyzed in 10 mM Tris (pH 8.0), 1 mM Tris(2-carboxye-
thyl)phosphine hydrochloride (TCEP), and flash frozen at 280ºC.
Proteolytic Domain Mapping
Proteolysis experiments were carried out at 37ºC at a 50:1 AcrA:ther-
molysin mass ratio in 10 mM Tris (pH 8.0), 0.15 mM ZnSO4, 2 mM
CaCl2. The final concentration of AcrA(26–397)-His was 1 mg/ml in
a 100 ml reaction. Ten microliter samples were taken at varying times
points, mixed with 23 SDS-PAGE sample buffer, boiled, and ana-
lyzed by 12% SDS-PAGE. Proteolysis fragments were identified us-
ing N-terminal sequencing of bands isolated by SDS-PAGE, and liq-
uid chromatography followed by electrospray ionization mass
spectrometry of the proteolysis reaction.
Crystallization and Data Collection
Crystals were grown at 4ºC by the vapor diffusion method using a 1:1
mixture of AcrA(45–312)-4M and 30% 2-methyl-2,4-pentadiol, 20
mM MgCl2, 100 mM citrate (pH 5.4), 1 mM TCEP. Crystals were
briefly washed in well buffer supplemented with fresh 1 mM TCEP,
mounted in fiber loops, and flashed cooled in liquid N2. Inverse
beam, three-wavelength oscillation data (0.5º) were collected from
cryocooled crystals at beamline 19-BM (Advanced Photon Source,
Argonne, IL) to 3.5 A˚ resolution (Table 1). Data were processed using
HKL2000 (Otwinowski and Minor, 1997). The crystals belong to
space group C2221 with cell dimensions a = 88.7 A˚, b = 100.0 A˚,
and c = 332.6 A˚; four protein molecules are contained in the asym-
metric unit (60% solvent).
Structure Determination and Refinement
Selenomethionine sites were initially located with SHELXL (Shel-
drick and Schneider, 1997), with a total of 16 sites being located after
refinement with Sharp (de La Fortelle and Bricogne, 1997). The mo-
lecular model was built with O (Jones et al., 1991) after solvent flat-
tening with DM (CCP4, 1994). The initial model was refined against
a 2.7 A˚ resolution data set (beamline 8.3.2, Advanced Light Source,
Berkeley, CA) using TLS and noncrystallographic symmetry re-
strained refinement with REFMAC5 (Table 1) (CCP4, 1994). A ran-
dom 5% of data were omitted from refinement for Rfree calculations.
The model AcrA(45–312)-4M includes residues 54–299 with breaks
in the main chain density for residues 230–241 in molecules A, B,
and D. All residues are within allowed regions of the Ramachandran
plot.
Functional Analysis and Expression of AcrA Mutants
The functional integrity of AcrA truncated at residue 312, and of dou-
ble (F223M/L224M and L287M/L288M) and quadruple (F223M/
L224M/L287M/L288M) methionine substitution mutants were as-
sessed using minimum inhibitory assays, as described previously
(Tikhonova and Zgurskaya, 2004). For this purpose, PCR-amplified
fragments of acrA mutants were subcloned by replacement of the
corresponding EcoNI-XbaI (for AcrA truncated at residue 312) or
MscI-XbaI (for double and quadruple methionine substitution mu-tants) fragments of pAHisB plasmid (Tikhonova and Zgurskaya,
2004). AcrA mutants containing C-terminal His tags were expressed
in a single operon with AcrB under control of the native acrAB pro-
moter. Constructs were verified by DNA sequencing. Plasmids
were transformed into E. coli AG100AX (DacrAB::kan DacrEF::spe)
and cells were grown to midlogarithmic phase (A600 of 1.0). Luria-
Bertani broth media containing 2-fold increasing concentrations of
the antibiotic under investigation were inoculated with 2.5 3 104
cells per ml. Cell growth was determined after overnight incubation
at 37ºC. The steady-state level of expression for these constructs
was analyzed by immunoblotting with an anti-AcrA polyclonal anti-
body, as described previously (Tikhonova and Zgurskaya, 2004).
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